Biotech Stock Pops On Promising First In-Human CRISPR Gene-Editing Drug

Shares of Crispr Therapeutics (CRSP) jumped Tuesday after the biotech company's gene-editing approach showed early promise. But, in after-hours action, Crispr stock tumbled on a public offering.